What This Rule Change Covers
The Health Insurance Legislation Amendment (Listing of Selpercatinib) Determination 2026 is a federal rule change concerning the medicine Selpercatinib, made under the Health Insurance Act 1973. The determination relates to adding Selpercatinib to a listing under that Act.
The determination was registered on 30 July 2026 and is administered by the Department of Health, Disability and Ageing.
Current Status
The rule is no longer in force as of 12 October 2026, having been repealed. The source page does not specify why it was repealed or what, if anything, replaced it.
This item relates to Medicare and health insurance medicine listings rather than general business obligations. The source gives no details about pricing, eligibility criteria, or which patients or providers are affected.
Key Actions
- No action needed for most small businesses - this is a health insurance medicine listing change, not a workplace or tax rule.
- Health and medical practices dealing with Selpercatinib prescribing or billing can check the Federal Register of Legislation page at https://www.legislation.gov.au/F2026L01001 for the full legislative text and explanatory statement.
- This determination has already been repealed as of 12 October 2026, so confirming current arrangements rather than relying on this version is advised.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.